Name | Number of supported studies | Average coverage | |
---|---|---|---|
acinar cell | 4 studies | 74% ± 29% |
Insufficient scRNA-seq data for expression of CPA1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 100% | 2948605.20 | 328 / 328 | 70% | 3506.36 | 125 / 178 |
spleen | 98% | 473.43 | 236 / 241 | 0% | 0 | 0 / 0 |
ovary | 71% | 315.59 | 128 / 180 | 23% | 4.10 | 99 / 430 |
adrenal gland | 75% | 271.90 | 193 / 258 | 6% | 0.21 | 13 / 230 |
uterus | 71% | 252.02 | 120 / 170 | 8% | 0.34 | 36 / 459 |
adipose | 76% | 1355.03 | 913 / 1204 | 0% | 0 | 0 / 0 |
stomach | 72% | 440.81 | 257 / 359 | 4% | 12.39 | 11 / 286 |
liver | 72% | 371.81 | 162 / 226 | 4% | 6.62 | 15 / 406 |
breast | 72% | 830.62 | 331 / 459 | 2% | 0.05 | 19 / 1118 |
kidney | 70% | 231.99 | 62 / 89 | 1% | 0.10 | 11 / 901 |
prostate | 61% | 385.66 | 150 / 245 | 1% | 0.03 | 6 / 502 |
blood vessel | 61% | 656.72 | 809 / 1335 | 0% | 0 | 0 / 0 |
intestine | 54% | 265.11 | 521 / 966 | 5% | 87.39 | 28 / 527 |
bladder | 57% | 153.71 | 12 / 21 | 2% | 0.15 | 8 / 504 |
esophagus | 55% | 341.53 | 800 / 1445 | 2% | 0.05 | 4 / 183 |
lung | 50% | 194.14 | 289 / 578 | 2% | 0.16 | 26 / 1155 |
thymus | 45% | 192.32 | 296 / 653 | 1% | 0.13 | 9 / 605 |
skin | 43% | 248.87 | 774 / 1809 | 2% | 0.03 | 8 / 472 |
heart | 41% | 218.76 | 354 / 861 | 0% | 0 | 0 / 0 |
muscle | 40% | 146.42 | 318 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 39% | 166.07 | 366 / 929 | 0% | 0 | 0 / 0 |
brain | 35% | 130.01 | 927 / 2642 | 3% | 0.09 | 19 / 705 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.10 | 1 / 29 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.03 | 1 / 45 |
eye | 0% | 0 | 0 / 0 | 1% | 0.01 | 1 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0046686 | Biological process | response to cadmium ion |
GO_0006691 | Biological process | leukotriene metabolic process |
GO_0051603 | Biological process | proteolysis involved in protein catabolic process |
GO_0006508 | Biological process | proteolysis |
GO_0005615 | Cellular component | extracellular space |
GO_0005515 | Molecular function | protein binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0004181 | Molecular function | metallocarboxypeptidase activity |
Gene name | CPA1 |
Protein name | Carboxypeptidase A1 Carboxypeptidase A1 (EC 3.4.17.1) |
Synonyms | CPA |
Description | FUNCTION: Carboxypeptidase that catalyzes the release of a C-terminal amino acid, but has little or no action with -Asp, -Glu, -Arg, -Lys or -Pro . Catalyzes the conversion of leukotriene C4 to leukotriene F4 via the hydrolysis of an amide bond (By similarity). . |
Accessions | A0A2P1GJE1 ENST00000481342.5 A0A2P1GJE0 A0A2P1GJD9 C9JUF9 S4R433 A0A2P1GJD0 C9JQ63 A0A2P1GJF1 A0A2P1GJD3 ENST00000484324.1 A0A2P1GJE2 P15085 A0A2P1GJD5 A0A2P1GJD7 A0A2P1GJC9 ENST00000011292.8 C9JUZ4 ENST00000476062.5 ENST00000604896.5 A0A2P1GJD8 |